Cybin (HELP) Non-Current Assets (2021 - 2026)

Cybin (HELP) posted quarterly Non-Current Assets of $66.6 million for Q1 2026, up 3.22% year-on-year from $64.6 million in Q1 2025, and down 0.85% on a QoQ basis from $67.2 million in Q4 2025.

Cybin (HELP) Non-Current Assets (2021 - 2026) Analysis & Trends

Cybin (HELP) has reported Non-Current Assets for 6 consecutive years, with $66.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Assets rose 3.22% year-over-year to $66.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.5 million (changed N/A YoY) and the FY2026 annual result came in at $66.6 million, changed 0.0% from the prior year.
  • Non-Current Assets eased to $66.6 million in Q1 2026 per HELP's latest filing, from $67.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for HELP reached as high as $67.2 million in Q4 2025 and fell as low as $1.9 million in Q1 2023.
  • A 5-year average of $49.8 million and a median of $61.3 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets fell 2.49% — and 2024, when it surged 166.18%.
  • Year by year, Non-Current Assets stood at $22.5 million in 2022, then soared by 164.05% to $59.5 million in 2023, then rose by 3.29% to $61.5 million in 2024, then advanced by 9.37% to $67.2 million in 2025, then decreased by 0.85% to $66.6 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $66.6 million, $67.2 million, and $66.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Cybin 28.04 Mn 28.04 Mn - 66.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.64 Mn
Dec 31, 2025 67.22 Mn
Sep 30, 2025 66.67 Mn
Jun 30, 2025 67.16 Mn
Mar 31, 2025 64.57 Mn
Dec 31, 2024 61.46 Mn
Sep 30, 2024 61.33 Mn
Jun 30, 2024 61.33 Mn
Mar 31, 2024 61.96 Mn
Dec 31, 2023 59.50 Mn
Sep 30, 2023 23.04 Mn
Jun 30, 2023 38.59 Mn
Feb 28, 2023 1.90 Mn
Dec 31, 2022 22.53 Mn
Sep 30, 2022 23.63 Mn
Dec 31, 2021 20.64 Mn
Sep 30, 2021 20.66 Mn
Jun 30, 2021 20.56 Mn
Mar 31, 2021 20.25 Mn